The Department of Health and Family Welfare vide notification dated the 13th January, 2022 has issued the New Drugs and Clinical Trials (Amendment) Rules, 2022. The amendment has extended the scope of new drugs to include cell or stem cell derived product. Previously the definition of new drug under the New Drugs and Clinical Trials Rules only included stem cell derived product.
It is proposed that the regulated entities maybe mandated to maintain the record of all such communication, which are mandated to be communicated under the
The suggestion relating to the appointment process aims to achieve better shareholder participation in the appointment process of PIDs. For improving ease of doing business
It is proposed that merchant bankers, other than Banks, Public Financial Institution and their subsidiaries, shall undertake only those activities, which are related to securities
DoT has notified ‘Telecommunications (Administration of Digital Bharat Nidhi) Rules, 2024’. The rules provide for powers and functions of administrator, who will be responsible for
Stay up-to-date with the latest regulatory developments from Legality Alerts, directly in your inbox. Never miss another important regulatory compliance news alert.
Solutions
Resources
